Clinical Trial Update: Exogenous Melatonin in Intensive Care Unit Chronodisruption [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating exogenous melatonin for chronodisruption in intensive care units, with conditions including sleep deprivation and ICU psychosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intensive Care Unit Psychosis
• Sleep Deprivation

Drugs mentioned

• exogenous melatonin (melatonin)

Snippet

Sponsor: Saint-Joseph University | Conditions: Sleep Deprivation, Intensive Care Psychosis | Phase 3 | Status: UNKNOWN